FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 78 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,349,000 | +56.4% | 409,841 | +36.8% | 0.12% | +66.2% |
| Q2 2018 | $1,502,000 | -41.6% | 299,695 | -40.2% | 0.07% | -32.4% |
| Q1 2018 | $2,574,000 | -24.5% | 501,578 | -11.5% | 0.10% | -18.0% |
| Q4 2017 | $3,408,000 | +53.8% | 566,829 | +42.0% | 0.13% | +52.4% |
| Q3 2017 | $2,216,000 | +557.6% | 399,186 | +859.3% | 0.08% | +600.0% |
| Q4 2015 | $337,000 | -84.7% | 41,611 | -86.1% | 0.01% | -86.0% |
| Q3 2015 | $2,199,000 | +37.4% | 300,000 | +92.3% | 0.09% | +62.3% |
| Q2 2015 | $1,600,000 | +38.9% | 156,000 | +25.2% | 0.05% | +32.5% |
| Q1 2015 | $1,152,000 | – | 124,551 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $24,530,000,000 | 3.64% |
| Opaleye Management Inc. | 950,000 | $4,873,000 | 1.39% |
| DSC Advisors, L.P. | 1,187,604 | $6,092,000 | 1.28% |
| DAFNA Capital Management LLC | 335,500 | $1,721,000 | 0.84% |
| Vivo Capital, LLC | 855,000 | $4,386,000 | 0.62% |
| Stonepine Capital Management, LLC | 129,756 | $666,000 | 0.36% |
| Eversept Partners, LP | 107,500 | $551,475 | 0.26% |
| Tekla Capital Management LLC | 930,398 | $4,773,000 | 0.19% |
| Perceptive Advisors | 1,117,324 | $5,732,000 | 0.16% |
| Crestline Management, LP | 217,670 | $1,117,000 | 0.14% |